pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 1,486 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 2
    bleximenib besylate
    bleximenib besylate
    Refractory Acute Myeloid Leukemia$JNJ JOHNSON & JOHNSON
  • Phase 2
    bocunebart
    bocunebart [INN]
    Migraine H. Lundbeck AS
  • Phase 2
    bosakitug
    bosakitug [INN]
    Atopic Dermatitis (Atopic Eczema)$ACRS Aclaris Therapeutics, Inc.
  • Phase 2
← prev
page 33 of 50
next →
131
Pain89
Neurology1
botensilimab
botensilimab
Metastatic Colorectal Cancer
$AGEN AGENUS INC
  • Phase 2
    botulinum vaccine [serogroups A, A1, B and B1]
    Botulism U.S. Army Medical Research Institute of Infectious Diseases
  • Phase 2
    brexucabtagene autoleucel
    Tecartus (brexucabtagene autoleucel)
    B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphobla…$GILD GILEAD SCIENCES, INC.
  • Phase 2
    brilacidin
    brilacidin
    Chemotherapy Induced Oral Mucositis Innovation Pharmaceuticals Inc
  • Phase 2
    briquilimab
    briquilimab
    Chronic Urticaria$JSPR Jasper Therapeutics, Inc.
  • Phase 2
    brogidirsen
    brogidirsen
    Duchenne Muscular Dystrophy Nippon Shinyaku Co Ltd
  • Phase 2
    budoprutug
    budoprutug [INN]
    Membranous Glomerulonephritis$CLYM Climb Bio, Inc.
  • Phase 2
    buloxibutid sodium
    buloxibutid sodium
    Idiopathic Pulmonary Fibrosis Vicore Pharma AB
  • Phase 2
    bulumtatug fuvedotin
    bulumtatug fuvedotin [INN]
    Esophageal Squamous Cell Carcinoma (ESCC) Mabwell Shanghai Bioscience Co Ltd
  • Phase 2
    bupropion
    bupropion
    Type 1 Narcolepsy (Narcolepsy with Cataplexy) Bioron Pharma
  • Phase 2
    cabiralizumab
    cabiralizumab [INN]
    Pigmented Villonodular Synovitis Bristol-Myers Squibb Co
  • Phase 2
    cafelkibart
    cafelkibart [INN]
    Solid Tumor LaNova Medicines Ltd
  • Phase 2
    caffeine
    caffeine
    Respiratory Depression (Hypoventilation) OYE Therapeutics Inc
  • Phase 2
    calpurbatug
    calpurbatug [INN]
    Prosthetic Joint infections Trellis Bioscience Inc
  • Phase 2
    camonsertib
    camonsertib
    Solid Tumor XenoTherapeutics Inc
  • Phase 2
    camupepimut
    camupepimut
    Colorectal Cancer$ELTX Elicio Therapeutics, Inc.
  • Phase 2
    canerpaturev
    canerpaturev
    Metastatic Melanoma Takara Bio Inc
  • Phase 2
    cannabidivarin
    cannabidivarin
    Autism Spectrum Disorder (ASD)$JAZZ Jazz Pharmaceuticals plc
  • Phase 2
    canvuparatide hydrochloride
    canvuparatide hydrochloride
    Hypoparathyroidism$MBX MBX Biosciences, Inc.
  • Phase 2
    carbon monoxide
    carbon monoxide
    Sickle Cell Disease Hillhurst Biopharmaceuticals Inc
  • Phase 2
    carotuximab
    carotuximab
    Metastatic Castration-Resistant Prostate Cancer (mCRPC)$KAPA Kairos Pharma, LTD.
  • Phase 2
    casdozokitug
    casdozokitug
    Hepatocellular Carcinoma$CHRS Coherus Oncology, Inc.
  • Phase 2
    cemacabtagene ansegedleucel
    cemacabtagene ansegedleucel
    Primary Mediastinal B-Cell Lymphoma$ALLO Allogene Therapeutics, Inc.
  • Phase 2
    cemsidomide
    cemsidomide
    Anaplastic Large Cell Lymphoma (ALCL)$CCCC C4 Therapeutics, Inc.
  • Phase 2
    cenegermin
    Oxervate (cenegermin-bkbj)
    Non-Arteritic Anterior Ischemic Optic Neuropathy Dompe Farmaceutici SpA
  • Phase 2
    censavudine
    censavudine
    Amyotrophic Lateral Sclerosis Transposon Therapeutics Inc
  • Phase 2
    cerebrolysin
    Unspecified Neurologic Disorders EVER Neuro Pharma GmbH